Tactile Medical Strengthens Leadership with Appointment of Andrea Pearson to Board of Directors

Key Points from the Announcement

• Appointment Announcement: Tactile Systems Technology, Inc. (“Tactile Medical”; Nasdaq: TCMD), a medical technology company focused on therapies for chronic disorders, has appointed Andrea Pearson to its Board of Directors, effective March 9, 2026.
• Committee Assignments: Ms. Pearson will serve as a member of both the Compliance & Reimbursement and the Nominating & Corporate Governance Committees.
• Professional Background: Ms. Pearson brings over 25 years of executive experience in healthcare, spanning product development, customer acquisition, branding, marketing communications, and public relations.
• Growth Expertise: Most recently, Pearson served as Growth Advisor and Chief Marketing Officer at Harbor Health, an organization that integrates clinical care with health insurance coverage.
• Track Record at DispatchHealth: As Chief Growth Officer and previously Chief Marketing Officer at DispatchHealth, Pearson architected the company’s growth strategy, expanding business operations from two to over 50 U.S. markets and driving a 30-fold increase in revenue. This demonstrates her capability in rapidly scaling healthcare companies.
• HealthGrades Experience: At HealthGrades, a leading online platform connecting patients with providers, Pearson grew the consumer audience from one million monthly to one million daily visitors through her roles as Chief Marketing Officer and Executive Vice President/General Manager.
• Industry Recognition: The Board Chairman, Bill Burke, highlighted Pearson’s strong track record of driving growth and innovation, as well as her deep understanding of patient engagement within the healthcare ecosystem.
• Company Focus: Tactile Medical specializes in at-home therapies for underserved, chronic conditions such as lymphedema, lipedema, chronic venous insufficiency, and chronic inflammatory lung disease. The company collaborates with clinicians to expand clinical evidence, raise awareness, increase access, reduce healthcare costs, and improve patient quality of life.

Important Considerations for Shareholders

• Potential Share Price Impact: The appointment of Andrea Pearson, with her proven track record in scaling healthcare companies and driving substantial revenue growth, could be viewed positively by investors. Her expertise may accelerate Tactile Medical’s market expansion and strengthen its leadership in key therapeutic areas, potentially impacting future financial performance and shareholder value.
• Strategic Leadership Addition: Pearson’s experience in both operational and strategic roles at high-growth healthcare firms signals a commitment to further growth and innovation. Her involvement in the Compliance & Reimbursement and Nominating & Corporate Governance Committees is likely to support Tactile Medical’s regulatory, expansion, and governance objectives.
• Market Positioning: As Tactile Medical continues to build leadership in lymphatic dysfunction and airway clearance therapies, Pearson’s appointment may be pivotal in maintaining and expanding competitive advantage, which can be price-sensitive information for shareholders.

Investor Contacts

For further information, investors can reach out via:
Sam Bentzinger (Gilmartin Group)
[email protected]

Disclaimer

This article is for informational purposes only and should not be construed as investment advice or a recommendation to buy or sell any securities. Investors should conduct their own research and consult with their financial advisors before making any investment decisions.

View TACTILE SYSTEMS TECHNOLOGY INC Historical chart here